OpenURL Connection Search

Select item for more details and to access through your institution.

Daratumumab plus bortezomib or daratumumab plus lenalidomide as salvage therapy for patients with myeloma: initial follow-up of an Italian multicentre retrospective clinical experience by 'Rete Ematologica Pugliese'.
Published in:
Annals of Hematology, 2022, v. 101, n. 8, p. 1727, doi. 10.1007/s00277-022-04857-0
By:
- Mele, G.;
- Cascavilla, N.;
- Di Renzo, N.;
- Guarini, A.;
- Mazza, P.;
- Melillo, L.;
- Pavone, V.;
- Tarantini, G.;
- Curci, P.;
- Falcone, A. P.;
- Germano, C.;
- Mele, A.;
- Palazzo, G.;
- Palumbo, G.;
- Reddiconto, G.;
- Rossini, B.;
- Specchia, G.;
- Musto, P.;
- Pastore, D.
Publication type:
Article
Kinetics of peg-filgrastim after high-dose chemotherapy and autologous peripheral blood stem cell transplantation.
Published in:
Bone Marrow Transplantation, 2007, v. 40, n. 6, p. 579, doi. 10.1038/sj.bmt.1705772
By:
- Piccirillo, N.;
- De Matteis, S.;
- De Vita, S.;
- Laurenti, L.;
- Chiusolo, P.;
- Sorà, F.;
- Reddiconto, G.;
- d'Onofrio, G.;
- Leone, G.;
- Sica, S.
Publication type:
Article
Assessment of cellular origin and EBV status in a PTLD after double cord blood transplantation.
Published in:
2007
By:
- Reddiconto, G.;
- Chiusolo, P.;
- Fiorini, A.;
- Farina, G.;
- Laurenti, L.;
- Martini, M.;
- Marchetti, S.;
- Fadda, G.;
- Leone, G.;
- Sica, S.
Publication type:
Letter
Reply to ‘Absence of JAK-2 (Val617Phe) point mutations in multiple myeloma’ by Dr Qin Huang et al. referred to ‘Screening of JAK2 V617F mutation in multiple myeloma’ from Fiorini A et al. published in Leukemia 2006, October 20.
Published in:
2007
By:
- Fiorini, A.;
- Farina, G.;
- Reddiconto, G.;
- Palladino, M.;
- Rossi, E.;
- Za, T.;
- Laurenti, L.;
- Giammarco, S.;
- Chiusolo, P.;
- Leone, G.;
- Sica, S.
Publication type:
Letter
Eradication of JAK2 V617F mutation after allogeneic transplantation in a patient with myelofibrosis with myeloid metaplasia.
Published in:
2006
By:
- Fiorini, A.;
- Reddiconto, G.;
- Farina, G.;
- Marietti, S.;
- Palladino, M.;
- Chiusolo, P.;
- Leone, G.;
- Sica, S.
Publication type:
Letter
Screening of JAK2 V617F mutation in multiple myeloma.
Published in:
2006
By:
- Fiorini, A.;
- Farina, G.;
- Reddiconto, G.;
- Palladino, M.;
- Rossi, E.;
- Za, T.;
- Laurenti, L.;
- Giammarco, S.;
- Chiusolo, P.;
- Leone, G.;
- Sica, S.
Publication type:
Letter
Fungal Infections in Recipients of Hematopoietic Stem Cell Transplants: Results of the SEIFEM B-2004 Study—Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.
Published in:
Clinical Infectious Diseases, 2007, v. 45, n. 9, p. 1161, doi. 10.1086/522189
By:
- Pagano, L.;
- Caira, M.;
- Nosari, A.;
- Van Lint, M. T.;
- Candoni, A.;
- Offidani, M.;
- Aloisi, T.;
- Irrera, G.;
- Bonini, A.;
- Picardi, M.;
- Caramatti, C.;
- Invernizzi, R.;
- Mattei, D.;
- Melillo, L.;
- de Waure, C.;
- Reddiconto, G.;
- Fianchi, L.;
- Valentini, C. G.;
- Girmenia, C.;
- Leone, G.
Publication type:
Article

Found: 7

Daratumumab plus bortezomib or daratumumab plus lenalidomide as salvage therapy for patients with myeloma: initial follow-up of an Italian multicentre retrospective clinical experience by 'Rete Ematologica Pugliese'.

Kinetics of peg-filgrastim after high-dose chemotherapy and autologous peripheral blood stem cell transplantation.

Assessment of cellular origin and EBV status in a PTLD after double cord blood transplantation.

Reply to ‘Absence of JAK-2 (Val617Phe) point mutations in multiple myeloma’ by Dr Qin Huang et al. referred to ‘Screening of JAK2 V617F mutation in multiple myeloma’ from Fiorini A et al. published in Leukemia 2006, October 20.

Eradication of JAK2 V617F mutation after allogeneic transplantation in a patient with myelofibrosis with myeloid metaplasia.

Screening of JAK2 V617F mutation in multiple myeloma.

Fungal Infections in Recipients of Hematopoietic Stem Cell Transplants: Results of the SEIFEM B-2004 Study—Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.